
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems.
Kymera is seeking an experienced nonclinical toxicologist to oversee the strategy, design, analysis, interpretation, and reporting of Toxicology and Safety Pharmacology data for discovery and development teams. The successful candidate will provide expert nonclinical safety support, guidance, and strategy for Kymera's degrader projects, ranging from discovery programs to advanced clinical programs.
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems.
Eikon Therapeutics